S
Shenzhen Shunshi Juhe Biotechnology
A contributor in the field of early diagnosis of gynecological tumors
About Shenzhen Shunshi Juhe Biotechnology
Cispoly is dedicated to developing innovative solutions for women's health, with a particular focus on early oncological diagnosis and cervical cancer screening. The company collaborates with medical associations and hospitals to conduct cutting-edge research, such as studies on DNA methylation in gynecological screening. Cispoly's business model revolves around identifying real clinical needs, understanding them through creative thinking, and meeting them with practical solutions that benefit a broader population. The company operates in the healthcare market, specifically targeting women's health, and generates revenue through the development and sale of diagnostic tools and screening services. By prioritizing long-term product strategies and leveraging innovation, Cispoly aims to become a leading brand in early cancer diagnosis.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 4
- Open positions
- None listed
- Dealroom signal
- 25.3/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Oncology, Health Diagnostics, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Dec 2023 | $28M | $110M | Sunland fund · Prosperity7 Ventures | ↗ |
| SERIES A✓Equity / VC | Apr 2022 | $14M | $55M | Haibang Capital | — |
Growth signals
Latest recorded traffic for Shenzhen Shunshi Juhe Biotechnology is 220 monthly website visits, up 0% over the last three months. Shenzhen Shunshi Juhe Biotechnology's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Shenzhen Shunshi Juhe Biotechnology in the Ningbo ecosystem
The Shenzhen Shunshi Juhe Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Series A3 investors entered at this stage
- HCHaibang Capital
Sunland fund
Prosperity7 Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Shenzhen Shunshi Juhe Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shenzhen Shunshi Juhe Biotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










